Jane Street
PDSB icon

Jane Street’s PDS Biotechnology PDSB Stock Holding History

Jane Street’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,800
Closed -$120K – 9184
2023
Q2 		$120K Buy
+23,800
New +$156K ﹤0.01% 7928

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Jane Street's PDSB Position: Q2 2026 in Review

Jane Street opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 279,664 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #9635 among its holdings. This is a return to the name: Jane Street previously reported a position in PDSB as recently as Q3 2025.

Jane Street first reported a position in PDSB in Q2 2018 and has held it in 15 quarters since. The position peaked at $762K in Q1 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Jane Street held 279,664 shares of PDS Biotechnology worth $246K as of Q2 2026.
  • PDS Biotechnology was a new Jane Street position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9635 holding.
  • Jane Street first reported a position in PDS Biotechnology in Q2 2018 and has held it in 15 quarters since.
  • Jane Street's PDS Biotechnology position peaked at $762K in Q1 2023.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.